Meningitis as a recurrent manifestation of anti-AQP4/anti-MOG negative neuromyelitis optica spectrum disorder: a case report

被引：0
|
作者：
Chenyang Zhang
Kang Zhang
Bing Chen
Jiao Yin
Miaomiao Dong
Yixin Qin
Xiao Yang
机构：
[1] General Hospital of Ningxia Medical University,Neuroscience Center
[2] Key Laboratory of Craniocerebral Diseases of Ningxia Hui Autonomous Region,Department of Neurology, Beijing Tiantan Hospital
[3] Capital Medical University,Department of Radiology
[4] China National Clinical Research Center for Neurological Diseases,undefined
[5] General Hospital of Ningxia Medical University,undefined
来源：
BMC Neurology | / 21卷
关键词：
Neuromyelitis optica spectrum disorders; Anti-aquaporin-4; Anti-myelin oligodendrocyte glycoprotein; Meningitis; Intracranial infection;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype
    Anne-Katrin Pröbstel
    Gabrielle Rudolf
    Klaus Dornmair
    Nicolas Collongues
    Jean-Baptiste Chanson
    Nicholas SR Sanderson
    Raija LP Lindberg
    Ludwig Kappos
    Jérôme de Seze
    Tobias Derfuss
    Journal of Neuroinflammation, 12
  • [32] Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype
    Proebstel, Anne-Katrin
    Rudolf, Gabrielle
    Dornmair, Klaus
    Collongues, Nicolas
    Chanson, Jean-Baptiste
    Sanderson, Nicholas S. R.
    Lindberg, Raija L. P.
    Kappos, Ludwig
    de Seze, Jerome
    Derfuss, Tobias
    JOURNAL OF NEUROINFLAMMATION, 2015, 12
  • [33] Does detection of anti-AQP4 antibodies trump clinical criteria for neuromyelitis optica?
    Weinshenker, Brian G.
    Carroll, William M.
    NEUROLOGY, 2011, 77 (09) : 812 - 813
  • [34] Neuromyelitis optica spectrum disorders positive for anti-AQP4 antibody associated with myasthenia gravis: A literature review
    Brignol, T. N.
    Leveziel, N.
    Urtizberea, J. A.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2019, 42 (03): : E131 - E132
  • [35] Frequency of anti-AQP4 and anti-MOG antibody positivity in patients with demyelinating diseases in Rio de Janeiro / Brazil
    Neri, V. C.
    Lopes, A.
    Batista, E.
    Camargo, S.
    Alvarenga, M. P.
    Araujo, A. C.
    Bento, C.
    Barros, P.
    Vasconcelos, C. F.
    Alvarenga, R. P.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 685 - 686
  • [36] A Devic's Neuromyelitis Optica (NMO) model in MOG-immunized brown Norway rats is associated with anti-AQP4 antibodies
    Collongues, Nicolas
    Blanc, Frederic
    Steibel, Jerome
    Lam, Chahn-Dao
    Trifilieff, Elisa-Beth
    Dinh, Danielle Pham
    Ghandour, Said
    De Seze, Jerome
    NEUROLOGY, 2008, 70 (11) : A31 - A32
  • [37] Radiculopathy in neuromyelitis optica. How does anti-AQP4 Ab involve PNS?
    Kim, Seungyeon
    Park, Joonghyun
    Kwon, Bum Sun
    Park, Jin-Woo
    Lee, Ho Jun
    Choi, Jin-Ho
    Nam, Kiyeun
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2017, 18 : 77 - 81
  • [38] Frequency of anti-aqp4 antibody in patients with neuromyelitis optica and optic spinal multiple sclerosis
    Papais Alvarenga, Regina Maria
    Linhares, Ulisses Cerqueira
    Alvarenga, Marcos Papais
    Alvarenga, Marina Papais
    Vasconcelos, Claudia C. F.
    Bento, Cleonice
    Thuler, Luiz Claudio
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (12) : 1853 - 1854
  • [39] Cell-based assay for anti-AQP4 antibody in Korean patients with neuromyelitis optica
    Kim, B. J.
    Han, S. G.
    Kang, E. S.
    Kim, M.
    Min, J. H.
    Vincent, A.
    Waters, P.
    Lee, K. H.
    MULTIPLE SCLEROSIS, 2010, 16 (10): : 1289 - 1290
  • [40] Validating the presence in serum of other biomarkers apart from anti-AQP4 antibodies for diagnosis of neuromyelitis optica spectrum disorders
    Diaz Sanchez, M.
    Garcia Miranda, P.
    Moron Civanto, F. J.
    Lebrato Hernandez, L.
    Martinez Olivo, M. M.
    Lamas Perez, R.
    Suarez Luna, N.
    Ramirez Lorca, R.
    Garcia Sanchez, M. I.
    Navarro, G.
    Casado Chocan, J. L.
    Ucles Sanchez, A. J.
    Romera, M.
    Echevarria, M.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 508 - 508
12345